Compare CMPS & POET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CMPS | POET |
|---|---|---|
| Founded | 2020 | 1972 |
| Country | United Kingdom | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.5B |
| IPO Year | 2020 | 2008 |
| Metric | CMPS | POET |
|---|---|---|
| Price | $13.84 | $8.25 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $25.38 | N/A |
| AVG Volume (30 Days) | 2.6M | ★ 11.5M |
| Earning Date | 05-07-2026 | 08-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $848.96 |
| Revenue Next Year | N/A | $700.00 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.29 | $3.87 |
| 52 Week High | $15.40 | $20.65 |
| Indicator | CMPS | POET |
|---|---|---|
| Relative Strength Index (RSI) | 59.41 | 47.09 |
| Support Level | $10.66 | $6.40 |
| Resistance Level | $14.84 | $9.15 |
| Average True Range (ATR) | 0.73 | 0.64 |
| MACD | 0.14 | 0.11 |
| Stochastic Oscillator | 79.97 | 47.31 |
Compass Pathways PLC is a biotechnology company focused on developing therapies for mental health conditions. Its research centers on a proprietary synthetic psilocybin formulation, COMP360, which is administered alongside psychological support. The company is conducting clinical trials to evaluate the safety and efficacy of this treatment in patients with treatment-resistant depression and other mental health disorders. The company operates in one operating segment.
POET Technologies Inc is a design and development company offering high-speed optical engines, light source products, and custom optical modules to the artificial intelligence systems market and hyperscale data centers. Its integration solutions are based on the POET Optical Interposer, a novel, patented platform that allows the seamless integration of electronic and photonic devices into a single chip using wafer-level semiconductor manufacturing techniques. POET's Optical Interposer platform also solves device integration challenges across a broad range of communication, computing, and sensing applications. The company operates geographically in the United States, Canada, Singapore and China.